BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29188357)

  • 1. [Management of valvular heart disease : ESC/EACTS guidelines 2017].
    Haude M
    Herz; 2017 Dec; 42(8):715-720. PubMed ID: 29188357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
    Vahanian A; Alfieri O; Andreotti F; Antunes MJ; Barón-Esquivias G; Baumgartner H; Borger MA; Carrel TP; De Bonis M; Evangelista A; Falk V; Lung B; Lancellotti P; Pierard L; Price S; Schäfers HJ; Schuler G; Stepinska J; Swedberg K; Takkenberg J; Von Oppell UO; Windecker S; Zamorano JL; Zembala M; ; ;
    Eur J Cardiothorac Surg; 2012 Oct; 42(4):S1-44. PubMed ID: 22922698
    [No Abstract]   [Full Text] [Related]  

  • 3. The 2017 ESC/EACTS guidelines on the management of valvular heart disease : What is new and what has changed compared to the 2012 guidelines?
    Baumgartner H
    Wien Klin Wochenschr; 2018 Mar; 130(5-6):168-171. PubMed ID: 29209824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications for surgery for valvular heart disease].
    Halbach M; Wahlers T; Baldus S; Rudolph V
    Dtsch Med Wochenschr; 2015 Nov; 140(23):1733-40. PubMed ID: 26583817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ESC/EACTS guidelines 2021 on the management of valvular heart diseases : What are the most important innovations?].
    Nettersheim FS; Baldus S
    Herz; 2022 Feb; 47(1):19-30. PubMed ID: 34609559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)].
    Vahanian A; Alfieri O; Andreotti F; Antunes MJ; Baron-Esquivias G; Baumgartner H; Borger MA; Carrel TP; De Bonis M; Evangelista A; Falk V; Iung B; Lancellotti P; Pierard L; Price S; Schafers HJ; Schuler G; Stepinska J; Swedberg K; Takkenberg J; Von Oppell UO; Windecker S; Zamorano JL; Zembala M;
    G Ital Cardiol (Rome); 2013 Mar; 14(3):167-214. PubMed ID: 23474606
    [No Abstract]   [Full Text] [Related]  

  • 7. [Commentary by the German Society for Thoracic and Cardiovascular Surgery on the positions statement by the German Cardiology Society on quality criteria for transcatheter aortic valve implantation (TAVI)].
    Cremer J; Heinemann MK; Mohr FW; Diegeler A; Beyersdorf F; Niehaus H; Ensminger S; Schlensak C; Reichenspurner H; Rastan A; Trummer G; Walther T; Lange R; Falk V; Beckmann A; Welz A; ;
    Thorac Cardiovasc Surg; 2014 Dec; 62(8):639-44. PubMed ID: 25415629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [When is surgery needed for minimally symptomatic or asymptomatic acquired valvulopathy?].
    Acar J; Michel PL; de Gevigney G
    Presse Med; 2000 Nov; 29(34):1867-75. PubMed ID: 11709821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ESC guidelines on the management of valvular heart disease. What has changed and what is new?].
    Mangner N; Schuler G
    Herz; 2013 Dec; 38(8):828-37. PubMed ID: 24169934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Echocardiography in Transcatheter Valvular Heart Disease Interventions.
    Khalique OK; Hahn RT
    Curr Cardiol Rep; 2017 Oct; 19(12):128. PubMed ID: 29075913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit.
    Mohammed S; El-Menyar A; Al-Janubi H; Shabana A; Alanazi Z
    Curr Vasc Pharmacol; 2018 Jan; 16(2):107-113. PubMed ID: 28393705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease.
    Ten Berg J; Sibbing D; Rocca B; Van Belle E; Chevalier B; Collet JP; Dudek D; Gilard M; Gorog DA; Grapsa J; Grove EL; Lancellotti P; Petronio AS; Rubboli A; Torracca L; Vilahur G; Witkowski A; Mehilli J
    Eur Heart J; 2021 Jun; 42(23):2265-2269. PubMed ID: 33822924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of transcatheter valve treatment.
    Liu XB; Wang JA
    J Zhejiang Univ Sci B; 2013 Aug; 14(8):670-5. PubMed ID: 23897785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiplatelet or anticoagulative strategies after surgical/interventional valve treatment].
    Jobs A; Stiermaier T; Klotz S; Eitel I
    Herz; 2018 Feb; 43(1):26-33. PubMed ID: 29147971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CardioPulse: Valvular interventions from the Europeanperspective.
    Vahanian A
    Eur Heart J; 2016 Mar; 37(10):796-7. PubMed ID: 26951576
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indication and timing of heart valve surgery - summery of the European guidelines].
    Sündermann SH; Reser D; Czerny M; Falk V
    Praxis (Bern 1994); 2014 Apr; 103(8):445-51. PubMed ID: 24713380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2020 update of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGHTG) on the position statement of the ÖKG and ÖGHTG for transcatheter aortic valve implantation 2011.
    Lamm G; Hammerer M; Hoppe UC; Andreas M; Berger R; Binder RK; Bonaros N; Delle-Karth G; Frick M; Grund M; Metzler B; Neunteufl T; Pichler P; Schmidt A; Wisser W; Zierer A; Seitelberger R; Grimm M; Geppert A;
    Wien Klin Wochenschr; 2021 Aug; 133(15-16):750-761. PubMed ID: 33755758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Vahanian A; Alfieri OR; Al-Attar N; Antunes MJ; Bax J; Cormier B; Cribier A; De Jaegere P; Fournial G; Kappetein AP; Kovac J; Ludgate S; Maisano F; Moat N; Mohr FW; Nataf P; Pierard L; Pomar JL; Schofer J; Tornos P; Tuzcu M; van Hout B; von Segesser LK; Walther T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):1-8. PubMed ID: 18502659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.